about
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and post...
Read More
116.78
0.21
(0.18%)
383.7K
XNAS Volume
XNAS 22 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Icon PLC is on 04 Jun 2026 for the purpose of Icon PLC First Quarter Earnings Result for 2026
See details
Not Eligible
Mid Valuation
Technically Neutral
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..